Europe Defibrillator Market Overview and Growth by 2028

The Europe defibrillator market is expected to reach US$ 3,705.85 million by 2028 from US$ 2,692.93 million in 2021; it is estimated to grow at a CAGR of 4.7% during 2021–2028.

A defibrillator is a medical device used to deliver a dose of electric current to the heart in order to treat life-threatening cardiac dysrhythmias. This current supports restoring the heart to a regular, healthy rhythm. Defibrillators can be implantable, external, transvenous, or subcutaneous based on the type required for the treatment. Some external defibrillators, also known as automated external defibrillators (AEDs), are designed so that even untrained or laypersons will be able to use them. The growth of the Europe defibrillator market is attributed to the factors such as increasing prevalence of cardiovascular diseases (CVDs) and rising training and awareness programs on cardiopulmonary resuscitation (CPR) and automated external defibrillators (AEDs). However, product recalls are likely to affect the market negatively.

Europe Defibrillator Market Revenue and Forecast to 2028 (US$ Million)

Market Insights

Increasing Prevalence of Cardiovascular Diseases (CVDs)

Cardiovascular diseases (CVDs) are likely to remain the most significant cause of morbidity and mortality worldwide. According to the European Cardiovascular Disease Statistics, in Europe only, they account for 1.8 million deaths every year, or 36% of all deaths in the European Union. As per recent estimates, the EU has over 60 million people living with CVDs. Moreover, deaths from CVDs exceed fatalities from cancer (1.3 million every year in Europe; 26% of all deaths). In addition, according to the British Heart Foundation Factsheet 2021, around 7.6 million people are living with heart and circulatory diseases in the UK.

Consequently, heart attacks account for more than 100,000 hospital admissions in the UK each year, equating to 280 admissions every day or one every five minutes. With the advancement of the healthcare system and infrastructure, every 7 out of 10 people survive a heart attack in the UK compared to the 1960s where more than 7 out of 10 heart attacks in the UK were fatal. In addition, over 1.4 million people in the UK approximately 1 million males and 380,000 women have survived a heart attack. Thus, the rising incidence of cardiovascular diseases and heart attacks is expected to drive the European defibrillator market during the forecast period.

Product-Based Insights

Based on product, the Europe defibrillator market is segmented into implantable cardioverter defibrillator and external. The implantable cardioverter defibrillator is subsegmented into transvenous ICD and subcutaneous ICD. Similarly, the external defibrillator segment is subsegmented into manual, wearable, and fully automated external defibrillators. In 2021, the implantable cardioverter defibrillator segment held the largest share of the market. Moreover, the same segment is also expected to grow at the fastest rate in the coming years.

Europe Defibrillator Market, by Product – 2021 and 2028

End User-Based Insights

Based on end user, the defibrillator market is segmented into hospitals and clinics, prehospital care, public access, home care settings, and alternate care facilities. The hospitals and clinics segment held the largest share of the market in 2021. However, prehospital care is estimated to register the highest CAGR in the market during the forecast period.

• Get Top Key Market Trends of this report.
  This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

Free Sample PDF

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Companies in the Europe defibrillator market focus on the collaboration strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.

Europe Defibrillator Market – by Product

• Implantable Cardioverter Defibrillator
  • Transvenous ICD
  • Subcutaneous ICD
• External
  • Manual
  • Fully Automated External Defibrillators
  • Wearable

Europe Defibrillator Market – by End User  

• Hospitals and Clinics
• Prehospital Care
• Public Access
• Home Care Settings
• Alternate Care Facilities

Europe Defibrillator Market – by Country

• UK
• Germany
• France
• Italy
• Spain
• Austria
• Switzerland
• Sweden
• Norway
• Denmark
• Netherland
• Finland
• Portugal
• Romania
• Rest of Europe

Company Profiles

• Medtronic
• Abbott
• Boston Scientific Corporation
• Zoll Medical Corporation
• Koninklijke Philips N.V.
• Biotronik, INC.
• CU Medical Systems, INC.
• Progetti SRL
• Shenzhen Mindray Bio-Medical Electronics Co., LTD.
• Nihon Kohden Corporation

Report Scope

Europe Defibrillator Market Regional Insights

The regional trends and factors influencing the Europe Defibrillator Market throughout the forecast period have been thoroughly explained by the analysts at Insight Partners. This section also discusses Europe Defibrillator Market segments and geography across North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Europe Defibrillator Market Report Scope

Europe Defibrillator Market Players Density: Understanding Its Impact on Business Dynamics

The Europe Defibrillator Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Market players density refers to the distribution of firms or companies operating within a particular market or industry. It indicates how many competitors (market players) are present in a given market space relative to its size or total market value.

Major Companies operating in the Europe Defibrillator Market are:

1. Medtronic
2. Abbott
3. Boston Scientific Corporation
4. Zoll Medical Corporation
5. Koninklijke Philips N.V.

Disclaimer: The companies listed above are not ranked in any particular order.